To amend the Federal Food, Drug, and Cosmetic Act to establish standardized pathogen and microorganism testing of infant formula products and manufacturing facilities, to mandate notification of specific positive tests and inspection classifications, and for other purposes.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7867 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7867 To amend the Federal Food, Drug, and Cosmetic Act to establish standardized pathogen and microorganism testing of infant formula products and manufacturing facilities, to mandate notification of specific positive tests and inspection classifications, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 9, 2026 Ms. DeLauro (for herself, Mrs. Grijalva, Mr. Panetta, Ms. Jacobs, Ms. Norton, Ms. Wilson of Florida, Mr. Bishop, Ms. Williams of Georgia, Mr. Pappas, Mr. Quigley, Mr. Krishnamoorthi, Ms. Schakowsky, Ms. Tlaib, Mr. Thanedar, Ms. Ross, Mr. Van Drew, Ms. Dean of Pennsylvania, and Mr. Cohen) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to establish standardized pathogen and microorganism testing of infant formula products and manufacturing facilities, to mandate notification of specific positive tests and inspection classifications, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Infant Formula Safety Modernization Act of 2026''. SEC. 2. MEASURES TO ENHANCE THE SAFETY OF INFANT FORMULA. (a) Good Manufacturing Practices.-- (1) In general.--Section 412(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a(b)) is amended by adding at the end the following: ``(5)(A) The Secretary shall by regulation update the good manufacturing practices for infant formulas established under this subsection to require the manufacturer of an infant formula to conduct pathogen and microorganism testing of-- ``(i) the infant for